Managed Access Programs for BYL719, Alpelisib
Novartis
Novartis
CG Oncology, Inc.
Novartis
Janssen Research & Development, LLC
Gilead Sciences
Nuvalent Inc.
Cogent Biosciences, Inc.
SpringWorks Therapeutics, Inc.
Novartis
Regeneron Pharmaceuticals
Bayer
SpringWorks Therapeutics, Inc.
ImmunityBio, Inc.
ITM Solucin GmbH
Novartis
Taiho Oncology, Inc.
Cogent Biosciences, Inc.
Imaging Biometrics, LLC
Karyopharm Therapeutics Inc
Autolus Limited
Endevica Bio
Nuvalent Inc.
Janssen Scientific Affairs, LLC
AbbVie
USWM, LLC (dba US WorldMeds)
AbbVie
AbbVie
AbbVie
Takeda
AbbVie
xCures
NanOlogy, LLC
NanOlogy, LLC
Orca Biosystems, Inc.
Regeneron Pharmaceuticals
Incyte Corporation
NovoCure Ltd.
Nuvation Bio Inc.
Regeneron Pharmaceuticals
Novartis
Replimune Inc.
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Celgene
Juno Therapeutics, a Subsidiary of Celgene
Aragon Pharmaceuticals, Inc.
Janssen Research & Development, LLC
Novartis
Novartis
Gilead Sciences